These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6111685)

  • 1. Duration of protection accorded by live oral poliovirus vaccine.
    Thomson A
    Lancet; 1981 Apr; 1(8224):831-2. PubMed ID: 6111685
    [No Abstract]   [Full Text] [Related]  

  • 2. [Third oral polio immunization--what is the good of it?].
    Haas R; Petersen EE; Neumann-Haefelin D; Schnetter C
    Dtsch Med Wochenschr; 1973 Mar; 98(10):476-9. PubMed ID: 4348024
    [No Abstract]   [Full Text] [Related]  

  • 3. Poliomyelitis vaccines in Belgium: 20 years of experience.
    Andre FE
    Dev Biol Stand; 1979; 43():187-93. PubMed ID: 230109
    [No Abstract]   [Full Text] [Related]  

  • 4. [Poliomyelitis vaccination in Denmark].
    Petersen I
    Ugeskr Laeger; 1985 Jan; 147(4):265-9. PubMed ID: 3976028
    [No Abstract]   [Full Text] [Related]  

  • 5. Antibody to poliovirus in older children and young adults in Israel and the use of poliovaccines for the immunization of the seronegatives.
    Goldblum N; Kra-Oz Z; Swartz T
    Dev Biol Stand; 1979; 43():173-7. PubMed ID: 230108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Observation on immunizing effect of live trivalent oral poliomyelitis vaccine].
    Hu XM
    Zhonghua Yu Fang Yi Xue Za Zhi; 1982 Sep; 16(5):285-9. PubMed ID: 7151589
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunization against poliomyelitis: risk/benefit/cost in a changing context.
    Salk J
    Dev Biol Stand; 1979; 43():151-7. PubMed ID: 230106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of a supplemental dose of oral versus inactivated poliovirus vaccine.
    Moriniere BJ; van Loon FP; Rhodes PH; Klein-Zabban ML; Frank-Senat B; Herrington JE; Pallansch MA; Patriarca PA
    Lancet; 1993 Jun; 341(8860):1545-50. PubMed ID: 8099637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary and booster vaccination with an inactivated poliovirus vaccine (IPV) is immunogenic and well-tolerated in infants and toddlers in China.
    Li R; Li CG; Li Y; Liu Y; Zhao H; Chen X; Kuriyakose S; Van Der Meeren O; Hardt K; Hezareh M; Roy-Ghanta S
    Vaccine; 2016 Mar; 34(12):1436-43. PubMed ID: 26873055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Criteria for control of infectious diseases with poliomyelitis as an example.
    Evans AS
    Prog Med Virol; 1984; 29():141-65. PubMed ID: 6322231
    [No Abstract]   [Full Text] [Related]  

  • 11. [Relative immunity to poliomyelitis in children from 0 to 10, after the 4th National Polio Vaccination Day with trivalent oral type Sabin vaccination, in the area of greater São Paulo, SP (Brazil), 1982].
    Barbosa V; Waldman EA; Fujita M; Kitamura C; Waldman CC; Lacerda JP
    Rev Saude Publica; 1984 Feb; 18(1):19-29. PubMed ID: 6328635
    [No Abstract]   [Full Text] [Related]  

  • 12. Is there a need of "catch-up' polio vaccination in preadolescence?
    Wassilak SG; Hinman AR
    JAMA; 1981 Sep; 246(11):1239. PubMed ID: 6267330
    [No Abstract]   [Full Text] [Related]  

  • 13. [Oral immunization against poliomyelitis].
    Haas R
    Dtsch Med Wochenschr; 1973 Sep; 98(36):1682-3. PubMed ID: 4741244
    [No Abstract]   [Full Text] [Related]  

  • 14. [Humoral poliomyelitis immunity in children inoculated with a live poliomyelitis vaccine].
    Kaplan AS; Vasilevskaia NI; Kozhevnikov IN
    Vopr Virusol; 1984; 29(2):251-3. PubMed ID: 6328770
    [No Abstract]   [Full Text] [Related]  

  • 15. Poliomyelitis vaccination. Evaluation and direction in continuing application.
    Sabin AB
    Am J Clin Pathol; 1978 Jul; 70(1 Suppl):136-40. PubMed ID: 210653
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunization with oral poliovirus vaccine in China.
    Dong DX
    Prog Med Virol; 1985; 31():212-21. PubMed ID: 2982175
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevalence of poliovirus neutralizing antibodies in young adult women.
    Mayer TR; Balfour HH
    JAMA; 1981 Sep; 246(11):1207-9. PubMed ID: 6267329
    [No Abstract]   [Full Text] [Related]  

  • 18. [Revaccination by oral monovalent poliovaccine type 3 (author's transl)].
    Srámová H; Teplý V; Bernatziková V
    Cesk Epidemiol Mikrobiol Imunol; 1981 Mar; 30(2):95-100. PubMed ID: 6261973
    [No Abstract]   [Full Text] [Related]  

  • 19. Absence of humoral immunity to poliovirus in vaccinated individuals.
    Beuen K; White R; Kobayashi R; Farrell C
    Nebr Med J; 1988 Feb; 73(2):40-4. PubMed ID: 2832773
    [No Abstract]   [Full Text] [Related]  

  • 20. [Vaccination against poliomyelitis. Formation of immunity evaluated according to the results of serological surveys].
    Zabicka J
    Przegl Epidemiol; 1981; 35(3):385-9. PubMed ID: 6276928
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.